MedElevator
Войти в исследования Medicine · 2026
Anti-interferon-γ autoantibody-mediated immunodeficiency with disseminated Mycobacterium massiliense and secondary Sweet syndrome: A case report.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Jiajia, Han Zihao, Liu Jiajun, Wang Lili, Guo Jiguang
Аннотация
RATIONALE: The co-occurrence of adult-onset immunodeficiency syndrome mediated by anti-interferon-γ autoantibodies (AIGA-AOID), disseminated non-tuberculous mycobacterial (NTM) infection, and Sweet syndrome is a recognized but underreported triad, particularly in East Asian populations. Detailed case reports emphasizing diagnostic approach and integrated management remain valuable for improving clinical recognition.
PATIENT CONCERNS: A 70-year-old Asian female presented with a 1-year history of a progressive neck mass, a 6-month history of recurrent fever, and a painful cutaneous eruption on the face, trunk, and limbs.
DIAGNOSES: Evaluations revealed disseminated Mycobacterium massiliense infection involving lymph nodes, lung, and skin. Skin biopsy was consistent with Sweet syndrome. High-titer anti-interferon-γ autoantibodies (1:2500) were detected, confirming AIGA-AOID in the absence of HIV or other immunosuppression.
INTERVENTIONS: Combined therapy was initiated: rituximab (two weekly doses) with corticosteroids, and a 12-month oral antimycobacterial regimen (clarithromycin, moxifloxacin, linezolid).
OUTCOMES: The patient showed marked clinical improvement within 2 weeks, with resolution of fever and skin healing. Follow-up imaging at 3 months demonstrated significant regression of lymphadenopathy and lung consolidation.
LESSONS: Sweet syndrome can be a presenting sign of disseminated NTM disease. In immunocompetent-appearing adults, especially in endemic regions, this should prompt investigation for AIGA-mediated immunodeficiency. Early diagnosis and combined immunomodulatory-antimicrobial therapy are crucial for successful outcomes.
PATIENT CONCERNS: A 70-year-old Asian female presented with a 1-year history of a progressive neck mass, a 6-month history of recurrent fever, and a painful cutaneous eruption on the face, trunk, and limbs.
DIAGNOSES: Evaluations revealed disseminated Mycobacterium massiliense infection involving lymph nodes, lung, and skin. Skin biopsy was consistent with Sweet syndrome. High-titer anti-interferon-γ autoantibodies (1:2500) were detected, confirming AIGA-AOID in the absence of HIV or other immunosuppression.
INTERVENTIONS: Combined therapy was initiated: rituximab (two weekly doses) with corticosteroids, and a 12-month oral antimycobacterial regimen (clarithromycin, moxifloxacin, linezolid).
OUTCOMES: The patient showed marked clinical improvement within 2 weeks, with resolution of fever and skin healing. Follow-up imaging at 3 months demonstrated significant regression of lymphadenopathy and lung consolidation.
LESSONS: Sweet syndrome can be a presenting sign of disseminated NTM disease. In immunocompetent-appearing adults, especially in endemic regions, this should prompt investigation for AIGA-mediated immunodeficiency. Early diagnosis and combined immunomodulatory-antimicrobial therapy are crucial for successful outcomes.